-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Oruka Therapeutics, Maintains $73 Price Target

Benzinga·03/13/2026 14:41:44
Listen to the news
BTIG analyst Julian Harrison reiterates Oruka Therapeutics (NASDAQ:ORKA) with a Buy and maintains $73 price target.